Can the COVID-19 Pandemic Disrupt the Current Drug Development Practices?

Therapeutics and vaccines against the COVID-19 pandemic need to be developed rapidly and efficiently, given its severity. To maximize the efficiency and productivity of drug development, the world has adopted disruptive technologies and approaches in various drug development areas. Telehealth, chara...

Descripción completa

Detalles Bibliográficos
Autores principales: Won, Jung-Hyun, Lee, Howard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196831/
https://www.ncbi.nlm.nih.gov/pubmed/34064287
http://dx.doi.org/10.3390/ijms22115457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196831/
https://www.ncbi.nlm.nih.gov/pubmed/34064287
http://dx.doi.org/10.3390/ijms22115457

Ejemplares similares